Skip to main content

Currently Skimming:

Appendix B: Workshop Task and Agenda
Pages 123-132

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 123...
... The current state of the science for in vitro derivation of male and female gametes from embryonic or induced pluripotent stem cells, including achievements with other mammalian species, roadblocks that remain to producing human gametes, and near-term prospects for overcoming remaining scientific and technical barriers.
From page 124...
... Workshop Chair (virtual) 9:30am Current State of the Science for Early Human Stem Cell Transitions Ali Brivanlou (Rockefeller University)
From page 125...
... 11:30am Discussion Session 2b: The Oogenesis Pathway 11:40am Stem Cell–Derived Ovarian Germ Cells: The Rodent Paradigm Katsuhiko Hayashi (Kyushu University, Japan) 11:55am Stem Cell–Derived Ovarian Germ Cells: The Primate and Human Paradigm Mitinori Saitou (Kyoto University, Japan)
From page 126...
... 2:50pm Discussion 3:15pm Break Session 3: Implications of IVG If It Were in Clinical Practice Objectives 1. Explore how IVG technology could potentially impact fertility care.
From page 127...
... Session 4: Social, Ethical, and Legal Considerations Raised by IVG Objectives 1. Frame key social, ethical, and legal questions that arise when considering IVG as a potential clinical tool.
From page 128...
... 11:50am Discussion 12:30pm Lunch Session 6: Imagining a Potential Clinical Research Pathway for Human IVG Objectives 1. Outline the major scientific and ethical elements that would need to be addressed to move from the laboratory to a clinical trial.
From page 129...
... Keck 103 BREAKOUT 3: Translating IVG from Laboratory to Market Emerging technologies require extensive testing and approvals before clinical use. The breakout group will discuss pathways for IVG from laboratory to any potential clinical use, including validation assays and regulatory considerations.
From page 130...
... 10:35am Group 3 Report-Out and Discussion Jeffrey Kahn (Johns Hopkins University) Session 9: Participatory Public Engagement Around Reproductive Science Advances Objectives 1.
From page 131...
... Adashi (Brown University) Workshop Chair


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.